A clinical impression that alopecia areata occurs commonly in mongols finds no mention in standard textbooks of dermatology (Rook et al. 1972 , Fitzpatrick et al. 1971 or the dermatological literature. A survey was therefore conducted in order to determine the incidence of alopecia areata in mongols in comparison with a control group of subnormal individuals who were not mongols but who were institutionalized in the same hospitals.
A clinical impression that alopecia areata occurs commonly in mongols finds no mention in standard textbooks of dermatology (Rook et al. 1972 , Fitzpatrick et al. 1971 or the dermatological literature. A survey was therefore conducted in order to determine the incidence of alopecia areata in mongols in comparison with a control group of subnormal individuals who were not mongols but who were institutionalized in the same hospitals.
Alopecia areata is thought to be autoimmune in origin because it is found commonly in association with other autoimmune diseases such as Hashimoto's thyroiditis, pernicious anemia, autoimmune adrenal insufficiency and vitiligo (Cunliffe et al. 1969) . We took blood from those mongols found to have alopecia areata and searched for the presence of antibodies against antinuclear antigens, thyroid components and gastric parietal cells.
Results
One thousand individuals who were clinically diagnosed as suffering from mongolism were examined. Their ages ranged from 5 to 67 years (the average age in males was 30 years and in females 33 years). There were 560 males and 440 females. One thousand individuals who had causes of subnormality other than mongolism, who were of average age 40 years (543 male and 457 female) were examined for the presence of alopecia areata.
Out of 1000 mongols 60 were found to have alopecia areata (37 males and 23 females). Of these 60 patients 25 were found to have alopecia totalis or universalis. Only one case of alopecia areata was found amongst the group of 1000 subnormal controls.
Out of the 60 patients with alopecia areata 14 were found to have fluorescent antibodies in their sera. Four of these patients were male; 3 had weakly positive antibodies against thyroid epithelium and thyroid colloid and one had weakly positive antibodies against gastric parietal cells. Ten were female. One patient had a positive antinuclear factor of 1:80, one had positive gastric parietal cell antibodies and 8 had positive antibodies against thyroid epithelium or thyroid Requests for reprints may be sent to DDM colloid. Thus 3 out of 37 (8 %) of the male mongols had weakly positive antibodies against thyroid components. This is no more common than in the normal population. However, 8 out of 23 (35 %) female mongols had antibodies against thyroid components. In order to investigate this further blood was taken from 23 female mongols without alopecia areata who were matched for age. Four of these patients had positive fluorescent antibodies, 2 against antinuclear antigens and 2 against thyroid components.
Discussion
It has thus been shown that alopecia areata occurs commonly in mongol subjects. The incidence is 6% in comparison with 0.1 % in a subnormal population institutionalized in the same environment as the mongol subjects. It is not known what the incidence of alopecia areata is in a normal population, but in a selected population of dermatological outpatients, the incidence of alopecia areata is approximately 2%.
It is probable that the incidence of alopecia areata is higher than 6% in mongols. In this survey only the scalp and face of the patient were examined, unless alopecia areata was found, in which case the patient was completely undressed and examined. It is thus likely that cases of alopecia areata occuring only on covered hairbearing areas of the skin would have been missed. Also although often there was historical evidence that a patient had suffered from alopecia areata in the past but had subsequently recovered, such patients were not included in this series. The incidence of 6 % therefore represents the incidence of alopecia areata on the scalp or face among a group of mongols at any one particular time.
No relationship has been demonstrated between the presence of antibodies against thyroid components, antinuclear antigens or gastric parietal cells in male mongols with alopecia areata in comparison with those found in a normal male population. On the other hand 8 out of 23 (35 %) of the female mongols with alopecia areata were found to have antibodies against thyroid components, whereas only 2 out of 23 (9%) of the female mongols without alopecia areata had thyroid antibodies. However, the numbers involved are small. It would be useful to study a considerably larger group of mongols with alopecia areata, in comparison with mongols without alopecia areata, to determine if there is a statistical difference between these two groups.
There has been considerable interest in recent years in the relationship between autoimmunity and chromosomal abnormalities. It is well known that thyroid antibodies occur more commonly in mongols and their relatives (Mellon et al. 1963 , Fialkow 1970 . Workers have shown that alopecia areata occurs more commonly in thyroid disease (Muller & Winkelmann 1963 , Morgans 1964 ). There is controversy whether thyroid antibodies occur more commonly in alopecia areata (Cunliffe et al. 1969 , Kern et al. 1973 , Munro & Chanarin 1974 . However, it is of considerable interest that alopecia areata, a disease that currently is thought to be linked with autoimmune disease, has now been established to occur often in a chromosomal abnormality such as mongolism.
Summary
Mongols have been found to suffer from alopecia areata more commonly than would be expected by chance. One thousand individuals with mongolism were examined and 60 were found to have alopecia areata. A control group of subnormal individuals matched for age and sex were examined and only one case of alopecia areata was found. Because autoimmune phenomena are well described in chromosomal abnormalities and alopecia areata occurs more commonly in association with diseases known to be autoimmune, fluorescent antibodies were looked for in the sera of those mongols with alopecia areata. Male mongols with alopecia areata did not have increased incidence of fluorescent antibodies in their sera but 8 out of 23 female mongols (35 %) with alopecia areata had antibodies against thyroid components as compared with 2 out of the 23 female mongols (9%) without alopecia areata. The leukocyte migration inhibition (LMI) test was first developed by S0borg & Bendixen in 1967 and since then it has been widely used as an in vitro guide to in vivo cell-mediated immunity.
Effect of Mitogens
The test is carried out by taking 30 ml of heparinized venous blood, removing the white cells from the plasma, washing them to remove traces of serum and then packing the cells into capillary tubes by centrifugation. The cell-containing capillary tubes are then mounted in culture chambers, antigen is added and the chambers incubated for 18-24 hours. In control cultures the cells migrate out of the tubes into the chamber fan-wise, while in activated chambers, inhibition of migration occurs if the subject is sensitive to the antigen. The areas of migration are measured by planimetry and a migration index is calculated from the ratio of the area of migration in activated cultures to the area of migration in control cultures. An index of 1.0 indicates no inhibition, while values less than 1.0 indicate inhibition of migration.
Recently this system has been adapted to measure the response to mitogens such as phytohemagglutinin (PHA), as well as to antigens.
Full details of this modification have been published (Morison 1973 (Morison , 1974 . By comparing the response obtained in patients with defective cell-mediated immunity to that in normal controls it has been established that a dose of 5 /-tg/ml of PHA in the culture medium gave good separation between the normal and abnormal subjects. It was suggested that a migration index below 0.3 indicated a normal response to PHA. The results were reproducible and not agedependent. Furthermore an incubation period of six hours gave results comparable to those of twenty-four hours. At either six hours or twentyfour hours the test is of course much quicker than the lymphocyte transformation test.
Response to PHA has been measured in a number of conditions: active sarcoidosis (15 patients), systemic lupus erythematosus (3 patients), Hodgkin's disease (3 patients) and malignant lymphoma (1 patient). All except one patient with systemic lupus erythematosus gave abnormal results with an index above 0.3. One patient with Hodgkin's disease has been considered free of the disease for the past three years and yet still gives a very abnormal result. 'Present address: St John's Hospital, Lisle Street, London WC2H 7BJ
